The Maryland Department of Health’s Overdose Data to Action (OD2A) team recently convened a multiagency workgroup to assess the presence of xylazine in Maryland. The Xylazine in Maryland Workgroup (now the Emerging Drug Trends Workgroup) has released a report of their findings, which includes an examination of post-mortem toxicology data and drug-checking data from Maryland’s Rapid Analysis of…
